BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20217566)

  • 1. A potential therapeutic for pandemic influenza using RNA interference.
    Seth S; Templin MV; Severson G; Baturevych O
    Methods Mol Biol; 2010; 623():397-422. PubMed ID: 20217566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice.
    Zhou H; Jin M; Yu Z; Xu X; Peng Y; Wu H; Liu J; Liu H; Cao S; Chen H
    Antiviral Res; 2007 Nov; 76(2):186-93. PubMed ID: 17719657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA interference strategies as therapy for respiratory viral infections.
    DeVincenzo JP
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S118-22. PubMed ID: 18820571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
    DeVincenzo JP
    Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference of avian influenza virus H5N1 by inhibiting viral mRNA with siRNA expression plasmids.
    Zhou K; He H; Wu Y; Duan M
    J Biotechnol; 2008 Jun; 135(2):140-4. PubMed ID: 18456361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrodynamic delivery protocols.
    Rychahou PG; Evers BM
    Methods Mol Biol; 2010; 623():189-95. PubMed ID: 20217552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses.
    DeVincenzo JP
    Antivir Ther; 2012; 17(1 Pt B):213-25. PubMed ID: 22311654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The silent treatment: RNAi as a defense against virus infection in mammals.
    van Rij RP; Andino R
    Trends Biotechnol; 2006 Apr; 24(4):186-93. PubMed ID: 16503061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of siRNAs to prevent and treat influenza virus infection.
    Ge Q; Eisen HN; Chen J
    Virus Res; 2004 Jun; 102(1):37-42. PubMed ID: 15068878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model.
    Kim M; Shin D; Kim SI; Park M
    Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral applications of RNAi.
    Morris KV; Rossi JJ
    Curr Opin Mol Ther; 2006 Apr; 8(2):115-21. PubMed ID: 16610763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells.
    Park WS; Hayafune M; Miyano-Kurosaki N; Takaku H
    Gene Ther; 2003 Nov; 10(24):2046-50. PubMed ID: 14566364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
    Akhtar S; Benter I
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of bovine viral diarrhea virus replication by small interfering RNA and short hairpin RNA-mediated RNA interference.
    Lambeth LS; Moore RJ; Muralitharan MS; Doran TJ
    Vet Microbiol; 2007 Jan; 119(2-4):132-43. PubMed ID: 17052865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. siRNAs: their potential as therapeutic agents--Part II. Methods of delivery.
    Singh SK; Hajeri PB
    Drug Discov Today; 2009 Sep; 14(17-18):859-65. PubMed ID: 19540929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The promise of siRNAs for the treatment of influenza.
    Bennink JR; Palmore TN
    Trends Mol Med; 2004 Dec; 10(12):571-4. PubMed ID: 15567323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
    Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
    Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.